Leukemia Due to Defective Philips CPAP Devices

How Does Exposure to the Polyurethane Foam from the Philips Sleep Apnea Devices Lead to Leukemia?

During the manufacturing process of polyurethane foam, toluene diisocyanate and methylene diphenyldiisocyanate are used in large amounts. Both chemicals, which are present in polyurethane foam, are mutagenic, whereas the former is also a carcinogen. Exposure to toluene diisocyanate occurs via inhalation and, since the polyurethane foam in the Philips sleep apnea machines and ventilators contains it, people who use these devices can easily breathe it in as the material deteriorates.

According to the International Agency for Research on Cancer, toluene diisocyanate is a possible human carcinogen. For this reason, exposure to it is associated with numerous cancers, including leukemia. A study published in the British Medical Journal from 1996 found that polyurethane foam manufacturing workers have a significantly increased mortality rate because of the malignant diseases they develop. Furthermore, the Department of Health and Human Services deemed toluene diisocyanate "reasonably anticipated to be a human carcinogen."

When people use defective Philips sleep apnea machines and ventilators, they inevitably inhale the toluene diisocyanate in the polyurethane foam of the device, which subsequently enters their bloodstream. Since this agent is mutagenic and carcinogenic, it can lead to the development of leukemia within several years, as it directly reaches the bloodstream, where it can cause severe damage to the DNA of the cells. If you came to struggle with leukemia as a consequence of using a faulty Philips device, we strongly advise you to contact our expert team to find out whether you are eligible for compensation.

What Are the Eligibility Criteria for Filing a Philips CPAP Claim for Leukemia?

In the regrettable event that you developed leukemia as a result of using a Philips CPAP sleep apnea device or another defective product of this company, you may be entitled to financial compensation. However, to file a claim for your diagnosis, you must meet the following eligibility criteria:

• you must have a leukemia diagnosis
• you must have used your defective Philips device for at least 6 months
• you must file your claim within the statute of limitations

The statute of limitations, which is the timeframe within which you can seek compensation, is a very important aspect if you want to file a product liability claim. In the majority of states, it is 3 years from the moment of diagnosis. However, some states have a shorter or longer statute of limitations, which is why it is crucial to reach out to Atraxia Law as soon as you find out about your cancer, as the evaluation process is quite complex and time-consuming.

File Your Leukemia Claim with the Assistance of Our Team of Professionals

For over 35 years, we have been assessing product liability claims for a wide range of defective products, and our expert team is here to ease the legal process for you if you have leukemia caused by using a faulty Philips device. The only documents we will need from you are proof of you owning a CPAP, BiPAP, or ASV sleep apnea device and your medical records as evidence of your leukemia diagnosis.

We will thoroughly evaluate your situation and then let you know with certainty whether you can proceed with the legal process. If we find that you are eligible for filing a product liability claim with Philips, we will quickly guide you to a specialized attorney who will help you recover the maximum compensation you deserve for your suffering.